Zhengye Biotechnology Holding (ZYBT) Retained Earnings (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) reported Retained Earnings of -$271551.7 for Q4 2025, down 65119.42% year-over-year from N/an in Q4 2024, and down 101.15% quarter-over-quarter from -$135000.0 in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Retained Earnings (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has 3 years of Retained Earnings data on file, last reported at -$271551.7 in Q4 2025.
- Retained Earnings for Q4 2025 came in at -$271551.7, down 65119.42% year-over-year; the trailing twelve-month figure through Dec 2025 was -$271551.7 (down 65119.42% YoY), and the FY2025 annual result was -$275000.0, down 104.17% from the prior year.
- Retained Earnings declined to -$271551.7 in Q4 2025 per ZYBT's latest filing, from -$135000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $5.3 million in Q4 2023 and troughed at -$271551.7 in Q4 2025.
- A 3-year average of $1.2 million and a median of -$67291.2 in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings sank 99.99% in 2024, then tumbled 65119.42% in 2025.
- A 3-year view of Retained Earnings shows it stood at $5.3 million in 2023, then slumped by 99.99% to $417.65 in 2024, then plunged by 65119.42% to -$271551.7 in 2025.
- Business Quant data shows ZYBT's Retained Earnings at -$271551.7 in Q4 2025, -$135000.0 in Q2 2025, and $417.65 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Zhengye Biotechnology Holding | 5.49 Mn | 6.20 Mn | - | -271,551.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -271,551.75 |
| Jun 30, 2025 | -135,000.00 |
| Dec 31, 2024 | 417.65 |
| Dec 31, 2023 | 5.33 Mn |